Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2504 of 6351
-
Heart attack recovery goes remote: video exercise may boost rehab attendance
Disease control OngoingThe overall aim of the study is to evaluate if remote video exercise-based cardiac rehabilitation (exCR), offered as an alternative to centre-based exCR, can increase participation in exCR sessions post myocardial infarction (MI).
Sponsor: Sahlgrenska University Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Sit down and stop leaks: new electromagnetic chair may cure incontinence
Disease control CompletedHigh intensity focused electromagnetic (HIFEM) technology induces deep pelvic floor muscle contractions designed to deliver the equivalent of 11,200 Kegel exercise over 28 minutes, with the intention of increasing neuromuscular tone of the pelvic floor. This study will have looki…
Sponsor: Boston Urogynecology Associates • Aim: Disease control
Last updated Jun 26, 2026 13:37 UTC
-
Ultrasound to reveal if cosmetic creams can melt away foot calluses and corns
Symptom relief CompletedThis prospective, non-randomized, controlled study evaluated the efficacy of a topical cosmetic keratolytic preparation (serum and cream containing urea, salicylic acid, and collagen) in reducing the thickness and associated pain of hyperkeratotic foot lesions (calluses and corns…
Sponsor: Wroclaw University of Health and Sport Sciences • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can magnetic pulses ease Schizophrenia's 'Negative' symptoms?
Symptom relief OngoingTreatment of depression with repetitive transcranial magnetic stimulation (rTMS) has shown high evidence using high-frequency left dorsolateral prefrontal cortex (DLPFC) stimulation. The treatment of negative symptoms with the same protocol in schizophrenia is considered as possi…
Sponsor: University of Regensburg • Aim: Symptom relief
Last updated Jun 26, 2026 19:01 UTC
-
New ultrasound technique could speed up kidney disease diagnosis in the ER
Diagnosis Recruiting nowChronic kidney disease is a common global public health issue and its prevalence increased year by year. Early diagnosis and intervention can prevent further complications and comorbidities of long-term dialysis, cardiovascular events and mortality as well as improve the patients…
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
Tailored milk boosts preemie brain growth?
Disease control OngoingThis study is a randomized trial comparing 2 methods of human milk fortification for preterm infants in the neonatal intensive care unit (NICU). All participating infants will receive a human milk diet comprising maternal and/or donor milk plus multi-component and modular fortifi…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Massive pain trial aims to find new relief options
Symptom relief Recruiting nowThe purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions bec…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Prostate cancer drug darolutamide under Real-World microscope
Disease control OngoingThe purpose of this study is to find out in the real-world setting, if darolutamide is safe and effective for patients diagnosed with prostate cancer that has not spread to other parts of the body. When a patient is enrolled to the study, his/her physician would have already made…
Sponsor: Bayer • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New pill shows promise for controlling acromegaly Long-Term
Disease control Stopped earlyA phase 2, open label, long-term extension study designed to evaluate the safety and efficacy of paltusotine (formerly CRN00808; an oral selective nonpeptide somatostatin receptor type 2 biased agonist) in subjects with acromegaly.
Phase 2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Heart stent passes Real-World test: orsiro keeps arteries open
Disease control CompletedThe objective of this post-approval study is to confirm that the clinical performance of the Orsiro stent in a real-world setting is similar to the clinical performance observed for Orsiro in the BIOFLOW-V Investigational Device Exemption pivotal trial, as a condition of the US F…
Sponsor: Biotronik, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Brain and body boost: could home-based cognitive and physical training ease 'chemo brain' after breast cancer?
Symptom relief CompletedInvestigator general objective is therefore to study and compare the benefit of several methods of management of cognitive difficulties reported by patients during treatment for breast cancer, among several treatments, offered independently in patients' homes and supervised from …
Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Antibiotic vancomycin tested as PSC treatment – trial stopped early
Disease control Stopped earlyTo find out if vancomycin is a safe and effective therapy for primary sclerosing cholangitis. Funding Source - FDA OOPD
Phase 2/3 • Sponsor: Elizabeth Carey • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Zapping kidney nerves may tame tough blood pressure
Disease control CompletedRDN-CKD Study is a prospective, randomized (1:1, central randomization), double-blind (unblinded interventionalist and blinded study team at each center), sham controlled, multicenter feasibility study. The purpose of the RDN-CKD Study is to demonstrate that renal denervation (RD…
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Uterine scar tissue after fibroid surgery: who is at risk?
Knowledge-focused CompletedThis prospective, multicenter, observational study evaluated the prevalence of intrauterine adhesions after laparoscopic or laparotomic myomectomy and investigated clinical and surgical factors associated with their occurrence. Consecutive women who underwent laparoscopic or lapa…
Sponsor: Università degli Studi dell'Insubria • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
App that learns your habits could help tame diabetes
Disease control CompletedIn this project, the investigators will evaluate the efficacy of a novel approach to personalizing behavioral interventions for self-management of type 2 diabetes (T2DM) to individuals' behavioral and glycemic profiles discovered using computational learning and self-monitoring d…
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Brain scans reveal how a calming drug affects emotion in psychosis
Knowledge-focused CompletedThe purpose of this study is to better understand mental illness and will test the hypotheses that, while viewing affective stimuli, patient groups will show increased blood oxygenation level dependent (BOLD) signal by fMRI after lorazepam. This study will enroll participants be…
Phase 4 • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Smartwatch could screen for sleep apnea, study says
Diagnosis OngoingSleep Apnea Syndrome (SAS) is a common pathology affecting between 4 and 8% of the general population. It aggravates morbidity and cardio-metabolic mortality and is responsible for accidents related to vigilance disorders. It is estimated that 80%% of SAS cases are not diagnosed …
Sponsor: Withings • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Bladder cancer drug combo trial halted early – what does it mean?
Disease control Stopped earlyA study comparing nivolumab and bacterial drugs given to help the body's immune system in the bladder versus bacterial drugs alone in high risk bladder cancer participants.
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 26, 2026 18:24 UTC
-
Experimental gene therapy targets rare form of duchenne muscular dystrophy
Disease control CompletedOpen-label, single dose clinical trial of scAAV9.U7.ACCA via peripheral limb vein injection for Duchenne muscular dystrophy boys who have a duplication of exon 2.
Phase 1/2 • Sponsor: Megan Waldrop • Aim: Disease control
Last updated Jun 26, 2026 16:38 UTC
-
New directional brain stimulation aims to stop Parkinson's freezing
Disease control CompletedDeep brain stimulation of the NST is effective for cardinal motor signs in patients with idiopathic Parkinson's disease (IPD), its effects on gait disturbances, especially freezing of gait-FOG, and falls are variable from one patient to another, in part depending on the location …
Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC